MODERN APPROACHES TO ANTICOAGULANT THERAPY OF PULMONARY EMBOLISM: FOCUS ON RIVAROXABAN

MODERN APPROACHES TO ANTICOAGULANT THERAPY OF PULMONARY EMBOLISM: FOCUS ON RIVAROXABAN

The analytical article provides a modern state of the anticoagulant therapy in pulmonary thromboembolism. Major advantages and preferential use of direct selective peroral anticoagulants represented by thrombin inhibitor dabigatran and a Xa factor inhibitors composed of apixaban, edoxaban and rivaro...

Full description

Bibliographic Details
Main Authors:	O. V. Averkov, V. I. Vechorko
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-11-01
Series:	Медицинский совет
Subjects:	pulmonary artery embolism therapy secondary prevention anticoagulants rivaroxaban
Online Access:	https://www.med-sovet.pro/jour/article/view/2022

Similar Items

Massive Spontaneous Haemothorax after Rivaroxaban Therapy for Acute Pulmonary Embolism
by: Yan Denise Tan, et al.
Published: (2019-09-01)

Therapeutic potential of apixaban at different stages of management of patients with pulmonary thromboembolism
by: O. V. Averkov, et al.
Published: (2019-01-01)

Aspects of anticoagulant therapy in venous thromboembolism, pulmonary embolism. Focus on elderly patients
by: M. V. Romanova, et al.
Published: (2022-04-01)

Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021-10-01)

Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
by: Yijun Song, et al.
Published: (2023-02-01)

Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment
by: Giuseppe Di Tano, et al.
Published: (2020-06-01)

THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT
by: S. R. Gilyarevskiy
Published: (2016-06-01)

Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism
by: Kingsley Dah, et al.
Published: (2023-06-01)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
by: Jay M. Margolis, et al.
Published: (2016-10-01)

The Role of Rivaroxaban in the Treatment of Patients with Stable Coronary Artery Disease
by: O. V. Averkov
Published: (2019-10-01)

Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy
by: Pierpaolo Di Micco, et al.
Published: (2022-07-01)

Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
by: Abbas‎ Ghaysouri, et al.
Published: (2020-09-01)

CHANGE OF ANTICOAGULANT EFFECT OF RIVAROXABAN DURING A DAY
by: I. V. Gel’Tser, et al.
Published: (2015-08-01)

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
by: Yin Lu, et al.
Published: (2022-01-01)

Extended Anticoagulation After Pulmonary Embolism: A Multicenter Observational Cohort Analysis
by: Romain Chopard, et al.
Published: (2022-07-01)

EXTENDED THERAPY OF VENOUS THROMBOSIS BY ORAL ANTICOAGULANTS: FOCUS AT SAFETY
by: I. V. SCHASTLIVTSEV, et al.
Published: (2016-12-01)

THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM: AN EFFECT ON PULMONARY PERFUSION (PART 2)
by: O. V. Nikitina, et al.
Published: (2018-07-01)

A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)

APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES
by: O. V. Averkov
Published: (2016-01-01)

Treatment of deep vein thrombosis and pulmonary embolism: The present state of the art
by: Johannes eThaler, et al.
Published: (2015-07-01)

Safety and Effectiveness of Thrombolytic Therapy Compared with Standard Anticoagulation in Subjects with Submassive Pulmonary Embolism
by: Pınar Çimen, et al.
Published: (2019-05-01)

Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report
by: Bassem Al Hariri, et al.
Published: (2023-12-01)

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation
by: José Miguel Rivera-Caravaca, et al.
Published: (2021-07-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

The Clot Thickens: Diagnosing Acute Pulmonary Embolism as a Trigger for Chronic Obstructive Pulmonary Disease Exacerbation in the Setting of Anticoagulation Failure
by: Sameh Saleh, et al.
Published: (2020-09-01)

Value of thrombolytic therapy for submassive pulmonary embolism patients
by: Magda A Ahmed, et al.
Published: (2018-01-01)

Acute pulmonary embolism: Diagnosis and management
by: Harshwardhan Khandait, et al.
Published: (2023-09-01)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
by: Aleksandra Jakimczuk, et al.
Published: (2022-04-01)

Thrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial
by: Maryam Taherkhani, et al.
Published: (2015-10-01)

Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
by: Dong Lin, et al.
Published: (2021-11-01)

Prevention of heart embolic complications in atrial fibrillation: Possibilities of using rivaroxaban
by: I S Iavelov
Published: (2013-12-01)

Treatment of Pulmonary Embolism: a Decade of Experience
by: A. Nikonenko, et al.
Published: (2019-05-01)

VENOUS THROMBOSIS AND PULMONARY EMBOLISM
by: I. N. Bokarev, et al.
Published: (2011-08-01)

Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy
by: Daniela Paola Roggeri, et al.
Published: (2014-12-01)

Impact of dedicated outpatient pulmonary follow‐up for hospitalized patients with acute pulmonary embolism
by: Joseph G. Noto, et al.
Published: (2022-01-01)

Pregnancy and pulmonary embolism; a fatal challenge: literature review
by: Bahram Zarmehri, et al.
Published: (2021-09-01)

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
by: Cristiano Bortoluzzi, et al.
Published: (2022-10-01)

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines
by: Afsaneh Vazin, et al.
Published: (2022-12-01)

Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography
by: Ramin Artang, et al.
Published: (2021-10-01)